Quote:

---

Leronlimab does not cause serious adverse events. So, these SAEs were caused by the disease or other treatments. That bodes well for differentiating Leronlimab from placebo. That is the point I think NP was making.

---

I agree with you. And as much as those deaths sadden me, the fact that there were many of them raises my hope that we will achieve statistical significance.